Home › NDC Lookup › RxCUI directory › RxCUI 351855

Loratadine 10 MG Disintegrating Oral Tablet [Alavert] — RxCUI 351855

RxNorm drug concept · Semantic branded drug
RxCUI 351855 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI351855
Official nameLoratadine 10 MG Disintegrating Oral Tablet [Alavert]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAlavert 10 MG Disintegrating Oral Tablet; Alavert 10 MG 24HR Disintegrating Oral Tablet; 24 HR Alavert 10 MG Disintegrating Oral Tablet
FDA products mapped4
Package NDCs mapped6
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Loratadine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Loratadine is an antihistamine that temporarily relieves common allergy symptoms — things like a runny nose, sneezing, itchy or watery eyes, and an itchy nose or throat. It works f...
  • When taken as directed, loratadine is considered non-drowsy for most people. However, if you take more than the recommended daily amount, drowsiness can happen. So stick to the dos...
  • It depends on the age. Children 6 and older can take standard adult doses of most forms. Children 2 to under 6 can use the oral solution or chewable tablets, but at a lower amount....
  • You should check with your doctor before taking loratadine if you have liver or kidney disease. Your doctor may need to adjust your dose. It's not necessarily off-limits, but it's...
📖 Read our full Loratadine guide →

🕸️ Concept Web — How Loratadine 10 MG Disintegrating Oral Tablet [Ala... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Loratadine 10 MG Disintegrating Oral Tablet [Alavert] RxCUI 351855

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Loratadine 28889
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Alavert 352401
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Loratadine Disintegrating Oral Tablet 374597
    • Loratadine Disintegrating Oral Product 1295085
    • Loratadine Oral Product 1165336
    • Loratadine Pill 1165337
    • Loratadine Disintegrating Oral Tablet [Alavert] 369790
    • Alavert Disintegrating Oral Product 1296571
    • Alavert Oral Product 1174142
    • Alavert Pill 1174143
    • +4 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Loratadine 10 MG Disintegrating Oral Tablet SCD · 311373
  • Loratadine 10 MG SCDC · 316167
  • Loratadine Disintegrating Oral Tablet SCDF · 374597
  • Loratadine Disintegrating Oral Product SCDG · 1295085
  • Loratadine Oral Product SCDG · 1165336
  • Loratadine Pill SCDG · 1165337

Brand-Name Concepts

  • Loratadine 10 MG [Alavert] SBDC · 575624
  • Loratadine Disintegrating Oral Tablet [Alavert] SBDF · 369790
  • Alavert Disintegrating Oral Product SBDG · 1296571
  • Alavert Oral Product SBDG · 1174142
  • Alavert Pill SBDG · 1174143
  • Alavert BN · 352401

📦 FDA Products & Package NDCs

4 products · 6 package NDCs
6 package NDCs map to RxCUI 351855 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
69536-0190-60 60 BLISTER PACK in 1 CARTON (69536-190-60) / 1 TABLET, ORAL... Alavert Allergy Foundation Consumer Healthcare 2024-05-15
69536-0195-20 20 BLISTER PACK in 1 CARTON (69536-195-20) / 1 TABLET, ORAL... Alavert Allergy Foundation Consumer Healthcare 2024-10-31
69536-0195-60 60 BLISTER PACK in 1 CARTON (69536-195-60) / 1 TABLET, ORAL... Alavert Allergy Foundation Consumer Healthcare 2024-10-31
80070-0110-18 18 BLISTER PACK in 1 CARTON (80070-110-18) / 1 TABLET, ORAL... Alavert Allergy Foundation Consumer Brands 2021-04-02
80070-0110-60 60 BLISTER PACK in 1 CARTON (80070-110-60) / 1 TABLET, ORAL... Alavert Allergy Foundation Consumer Brands 2021-04-02
80070-0120-60 60 BLISTER PACK in 1 CARTON (80070-120-60) / 1 TABLET, ORAL... Alavert Allergy Foundation Consumer Brands 2021-04-02
Observed labelers: Foundation Consumer Brands (3) · Foundation Consumer Healthcare (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.